Winer, Arthur
Dotan, Efrat
Article History
Accepted: 13 June 2021
First Online: 1 October 2021
Compliance with Ethical Standards
:
: Arthur Winer has received speaker’s honoraria from OncLive for speaking at an educational event on gastrointestinal cancers. Efrat Dotan has received institutional research funding from OncoMed, Pfizer, Eli Lilly, MedImmune, AstraZeneca, GlaxoSmithKline, Incyte, and Boston Biomedical (SDP Oncology); and has received compensation from Boston Biomedical (SDP Oncology), QED, Basilea, and ARMO BioSciences for service as a consultant/advisor.
: This article does not contain any studies with human or animal subjects performed by any of the authors.